Clinical Trials Logo

Filter by:
NCT ID: NCT06072417 Active, not recruiting - Clinical trials for Chronic Thromboembolic Pulmonary Hypertension

HA Residents With PVD, SDB Assessed at HA (2840m) vs LA (Sea Level)

Start date: September 22, 2023
Phase: N/A
Study type: Interventional

To study the effect of relocation from 2840m (Quito) to sea level (Pedernales) in patients with pulmonary vascular diseases (PVD) defined as pulmonary arterial hypertension or chronic thromboembolic pulmonary hypertension (PH) who permanently live >2500m on sleep disordered breathing

NCT ID: NCT06071546 Active, not recruiting - Retinal Diseases Clinical Trials

Clinical Investigation of a New Version of MAIA Microperimeter on Healthy Subjects and Patients With Retinal Pathology

Start date: October 17, 2023
Phase: N/A
Study type: Interventional

The purpose of this pre-market, monocentric cross-sectional study is to evaluate the clinical usefulness of a new version of the MAIA device (MAIA) through an agreement with the established version of the MAIA microperimeter (MAIA 2013 EDITION). Moreover, the study aims to evaluate MAIA test-retest repeatability in comparison with MAIA 2013 EDITION and to evaluate MAIA safety and adverse events. These purposes will be achieved by collecting data of healthy subjects and patients with retinal pathology. All participants will undergo repeated microperimetric examinations with both devices during one single visit.

NCT ID: NCT06036407 Active, not recruiting - Hearing Loss Clinical Trials

Screening for Hearing Loss After Childhood Cancer

HEAR
Start date: July 5, 2022
Phase: N/A
Study type: Interventional

The HEAR-study pilots and evaluates a national, low-threshold screening program to detect hearing problems in Swiss adult childhood cancer survivors. Participants will conduct a hearing test in a local hearing aid shop and report about their experiences at the shop in questionnaires and interviews. The screening program will be evaluated using the RE-AIM framework.

NCT ID: NCT06003244 Active, not recruiting - Clinical trials for Chronic Thromboembolic Pulmonary Hypertension

High Altitude (HA) Residents With Pulmonary Vascular Diseases (PVD), 6 Minute Walk Distance (6MWD) Assessed at 2840m (HA) With and Without Supplemental Oxygen Therapy (SOT)

Start date: September 23, 2023
Phase: N/A
Study type: Interventional

The investigators aim to study the effect of SOT in participants with pulmonary vascular diseases (PVD) defined as pulmonary arterial hypertension or chronic thromboembolic pulmonary hypertension (PH) who permanently live >2500m on 6-minute walk distance (6MWD) assessed at 2840m.

NCT ID: NCT05999916 Active, not recruiting - Clinical trials for Healthy Participants

Evaluate the Safety and Feasibility of tACS With the Miamind Neurostimulator in Healthy Participants

MindStim
Start date: December 27, 2023
Phase: N/A
Study type: Interventional

The present study aims to assess the safety and feasibility of repeated transcranial alternating current stimulation (tACS) by the Miamind Neurostimulator in a cohort of healthy participants. Based on the findings of this investigation, subsequent clinical trials assessing the efficiency of tACS by the Miamind Neurostimulator for treatment of Alzheimer's Disease will be conducted.

NCT ID: NCT05997771 Active, not recruiting - Obesity Clinical Trials

A Personal Nutrition Advisor to Assist Remote Dietary Counselling for Weight Loss and Maintenance

PNA-ORIGINATE
Start date: August 25, 2023
Phase: N/A
Study type: Interventional

The purpose of the study is to assess the usability of the PNA and satisfaction with the treatment within the framework of usual care remote nutritional counselling for GLP-1-supported weight management and collect pilot data on its potential to support weight loss.

NCT ID: NCT05996302 Active, not recruiting - Clinical trials for Chronic Thromboembolic Pulmonary Hypertension

HA Residents With PVD, 6MWD Assessed at HA (2840m) vs LA (Sea Level)

Start date: July 5, 2023
Phase: N/A
Study type: Interventional

To study the effect of relocation from 2840m (Quito) to sea level (Pedernales) in patients with pulmonary vascular diseases (PVD) defined as pulmonary arterial hypertension or chronic thromboembolic pulmonary hypertension (PH) who permanently live >2500m on 6-minute walk distance (6MWD)

NCT ID: NCT05963646 Active, not recruiting - Clinical trials for Age-Related Macular Degeneration

Optical Coherence Tomography and Microperimetry Biomarker Evaluation in Patients With Geographic Atrophy Study

OMEGA
Start date: March 16, 2021
Phase:
Study type: Observational

This study is a biomarker evaluation study in patients with geographic atrophy secondary to age-related macular degeneration (AMD). The study evaluates microperimetry (fundus-controlled perimetry) and optical coherence tomography imaging for assessing changes in retinal sensitivity and anatomy over time.

NCT ID: NCT05933616 Active, not recruiting - Diabetes Mellitus Clinical Trials

Analysis of Volatile Organic Compounds in Patients With Type 1 Diabetes in Induced Hypoglycaemia With a Breath Analyser

VAARABreath
Start date: April 1, 2023
Phase: N/A
Study type: Interventional

The breath analysis (BreathSpec® device) data of all participants that were included into the VAARA study (NCT05771090) will be analysed, this includes data from up to 40 breath samples from each of the 10 participants who underwent 2 insulin-induced hypoglycaemic episodes during two visits. The primary objective is to find a possible association between volatile organic compounds (VOCs) measured by the BreathSpec® device and blood glucose. For this we will use descriptive statistics, correlation coefficients, as well as a Principal Component Analysis and a partial least squares discriminant analysis. Furthermore, the time lag between hypoglycaemia onset and change in VOCs will be quantified.

NCT ID: NCT05913934 Active, not recruiting - Clubfoot Clinical Trials

Clubfeet and Twins and Gait Analysis

Start date: April 29, 2023
Phase:
Study type: Observational [Patient Registry]

Children with clubfeet who were exclusively treated by Ursula Issler-Wüthrich for 3 to 14 years with manual-dynamic physiotherapy and their healthy twin siblings are compared using gait analysis. GaitUp sensors (kinematic) and footscan V9 (kinetic) are the systems used for this comparison. Nonparametric statistics are applied to verify aberrations.